anthydoc – Page 565

AstraZeneca to spend $445M to boost production of Lokelma at Texas plant

With sales of potential blockbuster Lokelma scaling up, AstraZeneca is bolstering its production of the hyperkalemia treatment with a $445 million injection of funds. The investment will increase the capabilities of AZ’s

October 15, 2025

News·Solutions

Particle Dynamics melds with former EuroAPI plant to debut new CDMO Codis

In addition to substantial spray drying capacity, new CDMO Codis says it’s also equipped to handle commercial-scale work on amorphous solid dispersions, particle engineering and finished dose manufacturing for pharma, consumer health

October 15, 2025

News·Solutions

Disruptive Innovation in MedTech: Evolving Characteristics and Modern Realities

Disruptive innovation has long driven paradigm shifts in medical devices, transforming care delivery, access, and outcomes. In 2025, the bar now includes demonstrated clinical performance, workflow re-engineering, reimbursement alignment, and real-world evidence

October 15, 2025

Solutions

CDC team running top survey on health and nutrition is laid off

Protecting the nation’s public health demands data, whether it be new measles cases, a surge in ER visits, or shifting patterns in obesity. The most recent job cuts at the Centers for

October 14, 2025

Opinion

LGBTQ+ clinicians hold the line, plan for future

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Happy STAT Summit week! Excited to see y’all in Boston. Still planning to come

October 14, 2025

Opinion

BioNTech’s African mRNA vaccine production push gets EU funding boost

As BioNTech works to establish a production footprint for mRNA vaccines in Africa, two EU groups have offered financial backing to the company’s efforts.

October 14, 2025

News·Solutions

Novo plant hit with FDA’s most serious inspection classification, portending possible delays for partners

The FDA has tagged Novo Nordisk’s newly acquired manufacturing facility in Indiana with an official action indicated label, which is the most severe of the three inspection classifications issued by the agency.

October 13, 2025

News·Solutions

Syngene: Transforming Monoclonal Antibody Manufacturing for the Next Wave of Biologics

October 13, 2025

News·Solutions

Product Development Outsourcing Needs Speed, Safety & Certainty

Ask the Expert Bryan Gilpin, President, Suntra MedTech Solutions Bryan Gilpin is President of Suntra MedTech Solution. He’s a hands-on, engineering-oriented executive with experience developing, manufacturing, selling, distributing and supporting bio-medical equipment,

October 13, 2025

Featured

Sunrise Labs Rebrands as Suntra MedTech Solutions™

Press Release: MTI Staff was not involved in writing this content October 1, 2025 — Bedford, New Hampshire For over three decades, Sunrise Labs stood at the forefront of engineering excellence and

October 13, 2025

News·Solutions